Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

DXCM

Dexcom Inc

Dec 11 • 04:00PM ET

80.47

Dollar change 0.00
Percentage change 0.00	%

Healthcare • Medical Devices • USA • NASD

Peers: ABT MDT TNDM PODD BSX SENS GMED ZBH SYK TDOC

| Held by: VTI VOO QQQ VO SPY IVV VUG XLV VOT IWP

Scroll to Statements

Index	NDX, S&P 500	P/E	48.24	EPS (ttm)	1.67	Insider Own	1.29%	Shs Outstand	390.60M	Perf Week	-0.67%
Market Cap	31.43B	Forward P/E	39.46	EPS next Y	2.04	Insider Trans	-0.39%	Shs Float	385.55M	Perf Month	14.45%
Income	680.80M	PEG	2.24	EPS next Q	0.52	Inst Own	93.19%	Short Float	2.18%	Perf Quarter	16.93%
Sales	3.95B	P/S	7.95	EPS this Y	12.22%	Inst Trans	-3.27%	Short Ratio	2.02	Perf Half Y	-31.34%
Book/sh	5.07	P/B	15.88	EPS next Y	19.54%	ROA	10.51%	Short Interest	8.42M	Perf Year	-31.75%
Cash/sh	6.38	P/C	12.61	EPS next 5Y	21.55%	ROE	32.06%	52W Range	62.34 - 142.00	Perf YTD	-35.15%
Dividend Est.	-	P/FCF	58.75	EPS past 5Y	-	ROI	14.97%	52W High	-43.33%	Beta	1.13
Dividend TTM	-	Quick Ratio	2.12	Sales past 5Y	28.80%	Gross Margin	61.74%	52W Low	29.08%	ATR (14)	2.40
Dividend Ex-Date	-	Current Ratio	2.46	EPS Y/Y TTM	78.77%	Oper. Margin	15.88%	RSI (14)	63.91	Volatility	2.92% 3.58%
Employees	9600	Debt/Eq	1.31	Sales Y/Y TTM	16.19%	Profit Margin	17.22%	Recom	1.50	Target Price	96.29
Option/Short	Yes / Yes	LT Debt/Eq	1.30	EPS Q/Q	15.67%	Payout	0.00%	Rel Volume	0.00	Prev Close	80.47
Sales Surprise	0.38%	EPS Surprise	3.57%	Sales Q/Q	1.97%	Earnings	Oct 24 AMC	Avg Volume	4.18M	Price	80.47
SMA20	4.18%	SMA50	10.10%	SMA200	-18.82%	Trades		Volume	0	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-26-24	Downgrade	Robert W. Baird	Outperform → Neutral	$161 → $80
Jul-26-24	Downgrade	JP Morgan	Overweight → Neutral	$145 → $75
May-30-24	Initiated	Redburn Atlantic	Neutral	$130
Mar-12-24	Initiated	RBC Capital Mkts	Outperform	$165
May-30-23	Resumed	Morgan Stanley	Equal-Weight	$131
Apr-17-23	Upgrade	Raymond James	Outperform → Strong Buy	$127 → $138
Mar-29-23	Initiated	UBS	Buy	$142
Jan-26-23	Initiated	Wolfe Research	Outperform	$121
Oct-18-22	Initiated	Barclays	Equal Weight	$103
Oct-12-22	Initiated	Jefferies	Buy	$125
Jul-15-22	Initiated	Bernstein	Outperform	$105
Mar-02-22	Resumed	BofA Securities	Buy	$500
Feb-03-22	Upgrade	BTIG Research	Neutral → Buy	$535
Jan-19-22	Upgrade	Wells Fargo	Equal Weight → Overweight	$575
Jan-07-22	Upgrade	Guggenheim	Neutral → Buy	$580
Oct-18-21	Downgrade	Guggenheim	Buy → Neutral
Jul-21-21	Resumed	Cowen	Outperform	$540 → $525
May-28-21	Upgrade	Wells Fargo	Underweight → Equal Weight	$380
May-25-21	Initiated	Barclays	Overweight	$500
Apr-15-21	Initiated	Atlantic Equities	Overweight	$438

Show Previous Ratings

Dec-10-24 11:21AM	Dexcom shares up as Diabetes Association updates guidelines (Investing.com)
Dec-02-24 09:12AM	3 Reasons to Buy DexCom Stock Like There's No Tomorrow (Motley Fool)
Nov-28-24 07:45AM	2 Excellent Healthcare Stocks to Hold Through the Next Decade (Motley Fool)
Nov-27-24 09:28AM	Why Is DexCom, Inc. (DXCM) Among the Worst Performing Healthcare Stocks in 2024? (Insider Monkey)
Nov-26-24 09:50AM	Why DexCom (DXCM) is a Top Momentum Stock for the Long-Term (Zacks)
05:21PM	Loading…
Nov-25-24 05:21PM	DexCom, Inc. (DXCM): Innovation and Growth Catalysts Amid Strong Long-Term Outlook for Diabetes Care (Insider Monkey) +6.87%
Nov-24-24 10:15AM	2 Superior Growth Stocks to Buy Right Now If You have $1,000 to Invest (Motley Fool)
Nov-23-24 09:00AM	The Oura ring, the best Black Friday deals, and the safest states: Business news roundup (Quartz)
05:00AM	Oura ring's new trick, SpaceX smack talk, and Black Friday deals: The week's most popular stories (Quartz)
Nov-22-24 09:54AM	Heres Why DexCom (DXCM) Declined In Q3 (Insider Monkey)
05:00AM	Ozempic 2.0, the Oura ring's new trick, and RFK Jr. vs. vaccines: Pharma news roundup (Quartz)
05:00AM	Oura rings to track blood sugar, Vaccines vs RFK Jr., and Ozempic 2.0: Pharma news roundup (Quartz)
Nov-20-24 06:00AM	Dexcom invests $75M in ura, agrees to integrate smart rings and CGMs (MedTech Dive)
Nov-19-24 05:45PM	DexCom Pairs Its Glucose Monitor With URAs Smart Ring (Barrons.com)
11:15AM	Dexcom invests $75m in URA to forge partnership (Medical Device Network)
07:51AM	Loading…
07:51AM	Oura CEO on new partnership with Dexcom (CNBC TV)
06:00AM	The Oura ring will soon help you monitor your blood sugar (Quartz)
06:00AM	Dexcom and URA Announce Strategic Partnership (Business Wire)
06:00AM	Dexcom and OURA Announce Strategic Partnership (Business Wire)
Nov-15-24 12:12PM	DexCom, Inc. (DXCM): Among 12 High Growth Large Cap Stocks to Buy Now (Insider Monkey)
Nov-14-24 06:00AM	Dexcom Helps People With Diabetes Take the First Step to Discover What Theyre Made Of on World Diabetes Day (Business Wire)
Nov-12-24 04:43PM	S&P 500 Gains and Losses Today: Mosaic Stock Slumps After Earnings Miss (Investopedia) +5.73%
Nov-08-24 10:15AM	1 Stock to Buy Near Its 52-Week Low and Hold for 10 Years (Motley Fool)
Nov-01-24 12:29PM	DexCom (DXCM) Fell Due to an Uncharacteristic Earnings Miss (Insider Monkey)
Oct-30-24 03:02PM	Is DexCom, Inc. (NASDAQ:DXCM) The Worst Performing S&P 500 Stock In 2024? (Insider Monkey)
12:44PM	Heres Why DexCom (DXCM) Detracted in Q3 (Insider Monkey)
09:14AM	Multiple Headwinds Dragged DexCom (DXCM) in Q3 (Insider Monkey)
Oct-28-24 09:50AM	Here's Why DexCom (DXCM) is a Strong Momentum Stock (Zacks)
Oct-26-24 04:02AM	Decoding DexCom Inc (DXCM): A Strategic SWOT Insight (GuruFocus.com)
Oct-25-24 05:53PM	Why DexCom Stock Flopped on Friday (Motley Fool)
04:26PM	Loading…
04:26PM	Dexcom Pares Steep Losses Despite A Key Exec Departure Amid Stelo Launch (Investor's Business Daily)
12:05PM	Dexcom Reverses Losses Despite A Key Exec Departure Amid Stelo Launch (Investor's Business Daily)
11:47AM	Dexcom chief commercial officer to retire (MedTech Dive)
10:47AM	DexCom Beats Earnings Expectations. Why the Stock Is Trading Lower. (Barrons.com)
09:25AM	Analyst Report: DexCom, Inc. (Morningstar Research)
04:23AM	Jim Cramer On DexCom, Inc. (DXCM): I Lost Conviction After That Last Quarter (Insider Monkey)
03:21AM	DexCom Inc (DXCM) Q3 2024 Earnings Call Highlights: Navigating Growth and Challenges in a ... (GuruFocus.com)
Oct-24-24 10:30PM	DexCom (DXCM) Q3 2024 Earnings Call Transcript (Motley Fool)
05:30PM	DexCom (DXCM) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
05:15PM	Dexcom Crashes As A Key Executive Plans Departure Amid Stelo Launch (Investor's Business Daily)
05:15PM	DexCom (DXCM) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
04:25PM	Dexcom Tops Quarterly Expectations And Keeps Its Guidance. But Shares Crash. (Investor's Business Daily)
04:18PM	DexCom Q3 earnings beat estimates, but stock tumbles 16% on weak growth (Investing.com)
04:12PM	DexCom: Q3 Earnings Snapshot (Associated Press Finance)
04:03PM	Dexcom Reports Third Quarter 2024 Financial Results (Business Wire)
Oct-21-24 09:16AM	Stay Ahead of the Game With DexCom (DXCM) Q3 Earnings: Wall Street's Insights on Key Metrics (Zacks)
Oct-20-24 02:10PM	Is DexCom Inc. (DXCM) the Best QQQ Stock to Buy According to Analysts? (Insider Monkey)
10:02AM	Is DexCom, Inc. (DXCM) the Best IoT Stock To Buy Now? (Insider Monkey)
Oct-19-24 11:19AM	DexCom, Inc. (DXCM): Worst Performing NASDAQ Stock in 2024 (Insider Monkey)
Oct-18-24 04:00PM	RLF Urges DexCom, Inc. (NASDAQ: DXCM) Stockholders with Large Losses to Contact the Firm for Information About Their Rights (Business Wire)
08:00AM	Where Will DexCom Be in 5 Years? (Motley Fool)
Oct-17-24 10:01AM	Earnings Preview: DexCom (DXCM) Q3 Earnings Expected to Decline (Zacks)
Oct-15-24 07:14PM	Analyst Report: DexCom, Inc. (Morningstar Research)
11:04AM	DexCom (DXCM) Fell Due to Growth Deceleration (Insider Monkey)
05:45AM	DexCom, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - DXCM (PR Newswire)
Oct-12-24 11:40AM	2 Magnificent Stocks to Buy That Are Near 52-Week Lows (Motley Fool)
Oct-11-24 12:32PM	Is DexCom, Inc. (NASDAQ:DXCM) The Top Stock With Improving Technical Ratings According To Piper Sandler? (Insider Monkey)
Oct-09-24 12:38PM	Shareholders of DexCom, Inc. Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights DXCM (GlobeNewswire)
06:15AM	Down More Than 50% From Its High, Is DexCom Stock a Buy? (Motley Fool)
Oct-05-24 07:19AM	Jim Cramer Reports That DexCom, Inc. (DXCM) Is Down Roughly 41% (Insider Monkey)
06:45AM	2 Beaten-Down Growth Stocks You Might Regret Not Buying (Motley Fool)
05:43AM	Is DexCom a Millionaire Maker? (Motley Fool)
Oct-03-24 05:40PM	DXCM INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Case (GlobeNewswire)
12:39PM	DexCom (DXCM) Accused of Misleading Investors About Sales Force Changes and Financial Outlook - Hagens Berman (GlobeNewswire)
Oct-02-24 12:32PM	DexCom (DXCM) Accused of Misleading Investors About Sales Force Changes and Financial Outlook- Hagens Berman (Newsfile)
04:11AM	Down More Than 50%, Is DexCom Stock a Bargain Now? (Motley Fool)
Sep-30-24 03:29PM	DexCom (DXCM) Accused of Misleading Investors About Sales Force Changes and Financial Outlook- Hagens Berman (GlobeNewswire)
01:54PM	Investors in DexCom, Inc. Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights DXCM (GlobeNewswire)
07:15AM	2 Magnificent Growth Stocks Down 45% and 32% to Buy Right Now (Motley Fool)
Sep-27-24 08:08AM	DexCom (DXCM) Accused of Misleading Investors About Sales Force Changes and Financial Outlook - Hagens Berman (GlobeNewswire)
Sep-26-24 08:30AM	Dexcom Schedules Third Quarter 2024 Earnings Release and Conference Call for October 24, 2024 at 4:30 p.m. Eastern Time. (Business Wire)
Sep-25-24 12:01PM	Shareholders of DexCom, Inc. Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights DXCM (GlobeNewswire)
09:45AM	DexCom Is Great. Here's Why You Shouldn't Buy It. (Motley Fool)
08:07AM	Is DexCom a Millionaire Maker? (Motley Fool)
Sep-23-24 09:00AM	Dexcom, Beyond Type 2 and Retta Establish National Glucose Awareness Week to Close the Glucose Knowledge Gap (Business Wire)
Sep-22-24 06:00AM	Sugar High: How a Glucose Monitor Told Me Startling Things About My Diet (Barrons.com)
Sep-18-24 07:00AM	Dexcom Brings Mentorship to Centerfield, Welcomes New, Star Athletes to Its Ground-breaking NIL Program Dexcom U (Business Wire)
Sep-17-24 05:45AM	Shareholders of DexCom, Inc. Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights - DXCM (PR Newswire)
05:06AM	Uh-Oh! Alphabet Is Selling Its Stake in 2 Historically High-Flying Artificial Intelligence (AI) Stocks (Motley Fool)
Sep-14-24 05:30AM	2 Unstoppable Healthcare Stocks to Buy Right Now for Less Than $200 (Motley Fool)
Sep-12-24 10:15AM	3 Reasons DexCom Looks Like a No-Brainer Buy Right Now (Motley Fool)
Sep-11-24 01:18PM	DexCom, Inc. Sued for Securities Law Violations Investors Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights DXCM (GlobeNewswire)
Sep-10-24 06:29AM	Dexcom CGM Worn in Outer Space as Part of First-of-its-Kind Polaris Dawn Mission (Business Wire)
Sep-09-24 05:21PM	DexCom (DXCM) Faces Investor Backlash After Disappointing Earnings Report - Hagens Berman (GlobeNewswire)
Sep-06-24 07:33AM	DexCom (DXCM) Faces Investor Backlash After Disappointing Earnings Report - Hagens Berman (Newsfile)
Sep-05-24 02:59PM	DexCom (DXCM) Faces Investor and Analyst Backlash After Revealing Disappointing Growth - Hagens Berman (GlobeNewswire)
09:00AM	Heres Why DexCom (DXCM) Fell in Q2 (Insider Monkey)
08:45AM	DexCom, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DXCM (PR Newswire)
Sep-04-24 04:00AM	Dexcom to Showcase Transformational Impact of Dexcom CGM Technology at the EASD 2024 Conference Symposium (Business Wire)
Sep-03-24 05:12PM	S&P 500 Gains and Losses Today: Index Plunges To Start September (Investopedia)
12:40PM	DexCom Is the Best Performing Stock in the Nasdaq 100 Tuesday (Barrons.com)
Sep-02-24 02:00PM	DexCom (DXCM) Faces Investor and Analyst Backlash After Revealing Disappointing Growth - Hagens Berman (GlobeNewswire)
07:12AM	Is DexCom a Millionaire-Maker Stock? (Motley Fool)
Aug-30-24 02:01PM	DexCom (DXCM) Faces Investor and Analyst Backlash After Revealing Disappointing Growth Hagens Berman (GlobeNewswire)
08:06AM	DexCom Stock Got Crushed After an Earnings Miss. A New Product Could Bail It Out. (Barrons.com)
Aug-28-24 08:30AM	Dexcom Announces Upcoming Conference Presentation (Business Wire)
04:40AM	DexCom (DXCM) Accused of Misleading Investors - Hagens Berman (Newsfile)
Aug-26-24 04:25PM	Will New 'Milestone' Glucose Monitor Help Dexcom Stock Bounce Back? (Investor's Business Daily)
03:36PM	DexCom (DXCM) Accused of Misleading Investors - Hagens Berman (GlobeNewswire)
02:47PM	Jim Cramer Says One of the Most Dramatic Declines Of This Year Comes From DexCom Inc. (DXCM)' (Insider Monkey)

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Stern Sadie	EVP, Chief HR Officer	Nov 20 '24	Sale	74.73	4,259	318,275	71,192	Nov 22 04:15 PM
Sylvain Jereme M	EVP, Chief Financal Officer	Nov 15 '24	Sale	75.51	3,500	264,285	80,774	Nov 18 04:12 PM
JEREME SYLVAIN	Officer	Nov 15 '24	Proposed Sale	75.51	3,500	264,285		Nov 15 04:04 PM
Heller Bridgette P	Director	Sep 16 '24	Sale	70.00	1,000	70,000	24,349	Sep 17 04:17 PM
Heller Bridgette P	Director	Sep 16 '24	Proposed Sale	70.00	1,000	70,000		Sep 16 09:53 AM
Stern Sadie	EVP, Chief HR Officer	Sep 09 '24	Sale	69.15	426	29,458	75,451	Sep 11 07:05 PM
Sylvain Jereme M	EVP, Chief Financal Officer	Sep 09 '24	Sale	69.15	746	51,586	84,274	Sep 11 07:05 PM
Leach Jacob Steven	EVP, Chief Operating Officer	Sep 09 '24	Sale	69.15	746	51,586	264,915	Sep 11 07:05 PM
Brown Michael Jon	EVP, Chief Legal Officer	Aug 30 '24	Sale	70.00	686	48,020	65,636	Sep 03 04:22 PM
MICHAEL BROWN	Officer	Aug 30 '24	Proposed Sale	70.00	686	48,020		Aug 30 04:32 PM
Brown Michael Jon	EVP, Chief Legal Officer	Jul 31 '24	Sale	69.55	652	45,347	66,249	Aug 01 07:23 PM
MICHAEL BROWN	Officer	Jul 31 '24	Proposed Sale	69.55	652	45,347		Jul 31 04:04 PM
Brown Michael Jon	EVP Chief Legal Officer	Jun 28 '24	Sale	114.29	659	75,317	66,901	Jun 28 05:34 PM
FOLETTA MARK G	Director	Jun 18 '24	Sale	116.79	3,306	386,122	56,398	Jun 20 04:50 PM
FOLETTA MARK G	Director	Jun 17 '24	Sale	117.26	2,694	315,907	59,704	Jun 20 04:50 PM
Heller Bridgette P	Director	Jun 14 '24	Sale	113.55	1,000	113,550	25,349	Jun 18 07:16 PM
Sylvain Jereme M	EVP Chief Financial Officer	Jun 10 '24	Sale	115.05	745	85,713	84,948	Jun 11 06:39 PM
Stern Sadie	EVP Chief HR Officer	Jun 10 '24	Sale	115.05	427	49,127	75,877	Jun 11 06:39 PM
Leach Jacob Steven	EVP Chief Operating Officer	Jun 10 '24	Sale	115.05	745	85,713	265,577	Jun 11 06:38 PM
Brown Michael Jon	EVP Chief Legal Officer	May 31 '24	Sale	119.24	652	77,744	67,560	May 31 05:27 PM
Dolan Matthew Vincent	EVP Strategy and Corporate Dev	May 15 '24	Sale	126.58	2,423	306,703	40,075	May 16 04:04 PM
Brown Michael Jon	EVP Chief Legal Officer	Apr 30 '24	Sale	126.25	629	79,411	68,212	May 02 05:07 PM
Dolan Matthew Vincent	EVP Strategy and Corporate Dev	Apr 15 '24	Sale	137.81	1,990	274,242	42,377	Apr 16 04:16 PM
SAYER KEVIN R	President CEO and Chairman	Apr 08 '24	Sale	138.30	49,633	6,864,136	283,893	Apr 10 04:04 PM
Brown Michael Jon	EVP Chief Legal Officer	Mar 28 '24	Sale	140.04	2,624	367,472	68,682	Mar 29 07:30 PM
Stern Sadie	EVP Chief Human Resources	Mar 25 '24	Sale	140.00	4,137	579,180	76,304	Mar 26 04:46 PM
Dolan Matthew Vincent	EVP Strategy & Corp Dev	Mar 15 '24	Sale	130.21	4,203	547,259	44,367	Mar 19 04:55 PM
Sylvain Jereme M	EVP Chief Financial Officer	Mar 12 '24	Sale	134.41	11,661	1,567,363	85,534	Mar 14 05:40 PM
Stern Sadie	EVP Chief Human Resources	Mar 12 '24	Sale	133.61	20,321	2,715,006	80,441	Mar 14 05:40 PM
SAYER KEVIN R	President CEO and Chairman	Mar 12 '24	Sale	133.36	81,007	10,802,803	333,526	Mar 14 05:40 PM
Leach Jacob Steven	EVP Chief Operating Officer	Mar 12 '24	Sale	134.41	14,639	1,967,638	273,913	Mar 14 05:40 PM
Lawver Teri L	EVP Chief Commercial Officer	Mar 12 '24	Sale	134.41	4,764	640,333	66,641	Mar 14 05:39 PM
Dolan Matthew Vincent	EVP Strategy and Corporate	Mar 12 '24	Sale	134.41	6,710	901,896	48,570	Mar 14 05:39 PM
Brown Michael Jon	EVP Chief Legal Officer	Mar 12 '24	Sale	134.41	8,799	1,182,680	71,306	Mar 14 05:39 PM
Sylvain Jereme M	EVP Chief Financial Officer	Feb 20 '24	Sale	116.73	3,363	392,563	71,142	Feb 21 05:48 PM
Stern Sadie	EVP Chief Human Resources	Jan 16 '24	Sale	123.63	2,902	358,788	79,051	Jan 17 06:56 PM
Sylvain Jereme M	EVP Chief Financial Officer	Jan 16 '24	Sale	123.63	2,734	338,018	74,505	Jan 17 06:54 PM
SAYER KEVIN R	President, CEO and Chairman	Jan 16 '24	Sale	123.63	37,325	4,614,669	362,841	Jan 17 06:49 PM
Leach Jacob Steven	EVP Chief Operating Officer	Jan 16 '24	Sale	123.63	3,978	491,819	262,499	Jan 17 06:49 PM
ALTMAN STEVEN R	Director	Jan 16 '24	Sale	122.86	1,568	192,652	53,132	Jan 17 06:47 PM
AUGUSTINOS NICHOLAS	Director	Dec 15 '23	Sale	123.02	3,976	489,128	34,040	Dec 18 04:32 PM
ALTMAN STEVEN R	Director	Dec 15 '23	Sale	122.77	2,000	245,548	54,700	Dec 18 04:31 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DXCM

Dexcom Inc

Upgrade your FINVIZ experience